Immunovant Inc (IMVT) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immunovant Inc   (NASDAQ: IMVT)


Immunovant Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Immunovant Inc's ROI in the first quarter of 2026?
Immunovant Inc recorded a cumulative net loss of $-538 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -74.97%.

Within the Healthcare sector 568 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 3564 to 3917.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Investment Change TTM 18.27 % 20.3 % 18.63 % 29.42 % 36.64 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 735 853 707 576 654
Return On Investment (TTM) -74.97 % -72.5 % -70.21 % -72.75 % -73.7 %
IMVT's Overall Ranking # 3917 # 3564 # 3078 # 3636 # 3250
Seq. Investment Change TTM 2.93 % 5.49 % 3.51 % 5.23 % 4.7 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -538 -506 -464 -465 -447

IMVT Company Profile >> Back to IMVT Roi Comparisons >> See Annual IMVT Return On Investment



Return On Investment IMVT's Ranking
Within: No.
Industry # 93
Sector # 569
Overall # 3917

Return On Investment Statistics
High Average Low
-7.45 %
-57.56 %
-100.82 %
(Mar 31 2019)   (Mar 31 2020)







Financial Statements
Immunovant Inc's I. Quarter Investments $ 735 Millions IMVT's Balance sheet
Immunovant Inc's I. Quarter Income $ -153 Millions Quarterly IMVT's Income Statement
IMVT's Income by Division See IMVT's Income by Division


IMVT Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Investments in Millions 853 707 618 363 471
Y / Y Investment Growth 20.52 % 14.52 % 70.4 % -23.03 % 19.64 %
Net Income in Millions -506 -414 -259 -211 -157
Y / Y Net Income Growth - - - - -
Annual Return On Investment -59.3 % -58.5 % -41.98 % -58.19 % -33.27 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMVT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMVT's Competitors
Subscribers only: Roi for Immunovant Inc's Suppliers
Subscribers only: Return On Investment for IMVT's Customers

Other Ratios
IMVT's Roa IMVT's Inventory Turnover Ratio IMVT's Growth Rates IMVT's Dividend Statistics
IMVT's Profitability Ratios IMVT's Asset Turnover Ratio IMVT's Dividend Growth
IMVT's Roe IMVT's Valuation Ratios IMVT's Financial Strength Ratios IMVT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T18:14:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.